Food inequity and insecurity and MASLD: burden, challenges, and interventions.

Dana Ivancovsky-Wajcman, Patrizia Carrieri, Zobair M Younossi, Juan M Pericàs, Shira Zelber-Sagi, Jeffrey V Lazarus

Journal: Nature reviews. Gastroenterology & hepatology 2024;21(10):668-686

PMID: 39075288

Abstract

Liver disease prevalence, severity, outcomes and hepatic risk factors (for example, unhealthy diet) are heavily affected by socioeconomic status and food insecurity. Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent liver disease globally and is likely to co-occur with other liver diseases associated with food insecurity. Though weight reduction and adopting a healthy diet can reverse the course of MASLD, gaps between recommendations and practice transcend individual responsibility and preference. Broader sociocultural determinants of food choices (social nutrition) include food insecurity, community and social norms and the local environment, including commercial pressures that target people experiencing poverty, ethnic minorities and children. Food insecurity is a barrier to a healthy diet, as a low-quality diet is often less expensive than a healthy one. Consequently, food insecurity is an 'upstream' risk factor for MASLD, advanced fibrosis and greater all-cause mortality among patients with liver disease. Intervening on food insecurity at four major levels (environment, policy, community and health care) can reduce the burden of liver disease, thereby reducing social and health inequities. In this Review, we report on the current research in the field, the need for implementing proven interventions, and the role liver specialists can have.

© 2024. Springer Nature Limited.

Address: School of Public Health, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel. [email protected].; The Global NASH Council, Washington, DC, USA. [email protected].; Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.; Liver Unit, Vall d'Hebron University Hospital, Vall d'Hebron Institute for Research, Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain.; Johns Hopkins University-Pompeu Fabra University Public Policy Center, Barcelona, Spain.; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.; The Global NASH Council, Washington, DC, USA.; Beatty Liver and Obesity Research Program, Inova Health System, Falls Church, VA, USA.; The Global NASH Council, Washington, DC, USA.; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.; CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.